For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $1.51 in the prior trading day, Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) closed at $1.36, down -9.93%. In other words, the price has decreased by -$9.93 from its previous closing price. On the day, 0.23 million shares were traded. CYCC stock price reached its highest trading level at $1.45 during the session, while it also had its lowest trading level at $1.31.
Ratios:
Our goal is to gain a better understanding of CYCC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 0.91. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 21 ’23 when Rombotis Spiro George bought 6,070 shares for $3.31 per share. The transaction valued at 20,122 led to the insider holds 68,658 shares of the business.
McBarron Paul bought 1,886 shares of CYCC for $6,252 on Dec 21 ’23. The insider now owns 33,378 shares after completing the transaction at $3.31 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYCC now has a Market Capitalization of 1990564 and an Enterprise Value of -1548170. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.27 while its Price-to-Book (P/B) ratio in mrq is 2.37. Its current Enterprise Value per Revenue stands at -3.686 whereas that against EBITDA is 0.061.
Stock Price History:
The Beta on a monthly basis for CYCC is 0.62, which has changed by -0.85376346 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, CYCC has reached a high of $13.20, while it has fallen to a 52-week low of $1.41. The 50-Day Moving Average of the stock is -40.11%, while the 200-Day Moving Average is calculated to be -71.76%.
Shares Statistics:
The stock has traded on average 110.90K shares per day over the past 3-months and 471410 shares per day over the last 10 days, according to various share statistics. A total of 1.32M shares are outstanding, with a floating share count of 1.20M. Insiders hold about 8.89% of the company’s shares, while institutions hold 7.12% stake in the company. Shares short for CYCC as of 1713139200 were 38411 with a Short Ratio of 0.35, compared to 1710460800 on 26613. Therefore, it implies a Short% of Shares Outstanding of 38411 and a Short% of Float of 3.08.
Earnings Estimates
The company has 1.0 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$4.56 for the current quarter, with a high estimate of -$4.56 and a low estimate of -$4.56, while EPS last year was -$7.05. The consensus estimate for the next quarter is -$3.44, with high estimates of -$3.44 and low estimates of -$3.44.
Analysts are recommending an EPS of between -$13.38 and -$13.38 for the fiscal current year, implying an average EPS of -$13.38. EPS for the following year is -$24.37, with 1.0 analysts recommending between -$24.37 and -$24.37.
